Global Blood Therapeutics, Inc. EPS - Earnings per Share 2015-2022 | GBT
Global Blood Therapeutics, Inc. eps - earnings per share from 2015 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Global Blood Therapeutics, Inc. Annual EPS |
| 2021 |
$-4.81 |
| 2020 |
$-4.04 |
| 2019 |
$-4.57 |
| 2018 |
$-3.41 |
| 2017 |
$-2.76 |
| 2016 |
$-2.48 |
| 2015 |
$-3.95 |
| 2014 |
$-14.20 |
| 2013 |
$-16.14 |
| Global Blood Therapeutics, Inc. Quarterly EPS |
| 2022-06-30 |
$-1.26 |
| 2022-03-31 |
$-1.26 |
| 2021-12-31 |
$-1.35 |
| 2021-09-30 |
$-1.13 |
| 2021-06-30 |
$-1.12 |
| 2021-03-31 |
$-1.21 |
| 2020-12-31 |
$-1.01 |
| 2020-09-30 |
$-0.97 |
| 2020-06-30 |
$-0.86 |
| 2020-03-31 |
$-1.20 |
| 2019-12-31 |
$-1.62 |
| 2019-09-30 |
$-1.07 |
| 2019-06-30 |
$-1.01 |
| 2019-03-31 |
$-0.87 |
| 2018-12-31 |
$-0.93 |
| 2018-09-30 |
$-0.83 |
| 2018-06-30 |
$-0.78 |
| 2018-03-31 |
$-0.87 |
| 2017-12-31 |
$-0.95 |
| 2017-09-30 |
$-0.66 |
| 2017-06-30 |
$-0.55 |
| 2017-03-31 |
$-0.60 |
| 2016-12-31 |
$-0.76 |
| 2016-09-30 |
$-0.58 |
| 2016-06-30 |
$-0.58 |
| 2016-03-31 |
$-0.56 |
| 2015-12-31 |
$6.01 |
| 2015-09-30 |
$-0.90 |
| 2015-06-30 |
$-4.84 |
| 2015-03-31 |
$-4.22 |
| 2014-12-31 |
$-3.18 |
| 2014-09-30 |
$-3.53 |
| 2014-06-30 |
$-3.68 |
| 2014-03-31 |
$-3.81 |
